CompuMed press release regarding the reverse stock split
LOS ANGELES, Calif./ACCESSWIRE/April 20, 2022/ CompuMed, Inc. (OTC PINK: CMPD)a leader in diagnostic telemedicine, announced in March 2022 the approval by its shareholders of a 25:1 reverse stock split.
As previously reported, the Company is in the process of submitting the appropriate documentation to FINRA and its transfer agent, ComputerShare, to complete the stock consolidation as soon as possible, with an expected effective date of mid -May 2022; the Company will provide updates as the effective date approaches.
Inquiries in this regard can be addressed to [email protected]
About CompuMed, Inc.
CompuMed, Inc. (OTC PINK: CMPD) Diagnostic telemedicine services provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to US Board-certified specialists through cloud-based technology and integrated medical devices at medical facilities around the world. The company has been in business for over 26 years and serves over 1,000 clinical facilities. CompuMed is headquartered in Los Angeles, California. Visit CompuMed at www.compumedinc.com.
Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all passages containing words such as “will”, “aims”, “anticipates” , “become”, “believe”, “continue”, “estimate”, “expect”, “future”, “intend”, “plan”, “predict”, “project”, “target or “future.” Forward-looking statements also include any other statements that primarily relate to expected future events or that can only be assessed by events that will occur in the future. Forward-looking statements are based on opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by the forward-looking statements. Factors that could cause actual results to differ materially from current expectations and the forward-looking statements contained in this press release include, but are not limited to: the timing and volume of our customers’ business activities and our ability to continue to provide products and services to those customers; loss or reduction in business of significant customers; our liquidity and cash position; changes in technology; our ability to protect the Company’s net operating losses and tax benefits; volatility and changes in our stock price, business conditions or other market conditions; changes in government regulations or economic conditions; the impact of increased competition and pricing; capacity and supply chain constraints or difficulties; and other factors contained in Company filings posted on the OTC Markets website. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement to reflect events, conditions or circumstances on which such statement is based after the date hereof, except as required by law.
THE SOURCE: CompuMed, Inc.
See the source version on accesswire.com: